TREATMENT OF PARKINSONS-DISEASE WITH AGENTS OTHER THAN LEVODOPA AND DOPAMINE AGONISTS - CONTROVERSIES AND NEW APPROACHES

被引：34

|

作者：

LANG, AE

机构：

来源：

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES | 1984年 / 11卷 / 01期

关键词：

D O I：

10.1017/S0317167100046436

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

收藏

页码：210 / 220

页数：11

相关论文

共 50 条

[21] PARKINSONS-DISEASE - NEW APPROACHES TO DIAGNOSIS AND TREATMENT
YAHR, MD
ACTA NEUROLOGICA SCANDINAVICA, 1993, 87 : 22 - 25
[22] INTERACTIONS BETWEEN LEVODOPA AND OTHER DRUGS - SIGNIFICANCE IN TREATMENT OF PARKINSONS-DISEASE
BIANCHINE, JR
SUNYAPRIDAKUL, L
DRUGS, 1973, 6 (5-6) : 364 - 388
[23] SHOULD DOPAMINE AGONISTS BE GIVEN EARLY OR LATE IN THE TREATMENT OF PARKINSONS-DISEASE
RASCOL, A
MONTASTRUC, JL
RASCOL, O
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1984, 11 (01) : 229 - 232
[24] DOPAMINERGIC AGONISTS IN THE TREATMENT OF PARKINSONS-DISEASE
GOETZ, CG
DIEDERICH, NJ
NEUROLOGIC CLINICS, 1992, 10 (02) : 527 - 540
[25] DOPAMINERGIC AGONISTS IN THE TREATMENT OF PARKINSONS-DISEASE
GOETZ, CG
NEUROLOGY, 1990, 40 (10) : 50 - 54
[26] CLOZAPINE FOR THE TREATMENT OF LEVODOPA AND DYSKINESIA IN PARKINSONS-DISEASE
REES, G
MADELEY, P
IRISH JOURNAL OF PSYCHOLOGICAL MEDICINE, 1995, 12 (03) : 119 - 119
[27] PROTEIN INTAKE AND TREATMENT OF PARKINSONS-DISEASE WITH LEVODOPA
MENA, I
COTZIAS, GC
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (04): : 181 - 184
[28] CURRENT STATUS OF DOPAMINE AGONISTS IN PARKINSONS-DISEASE MANAGEMENT
MONTASTRUC, JL
RASCOL, O
SENARD, JM
DRUGS, 1993, 46 (03) : 384 - 393
[29] A RATIONALE FOR DOPAMINE AGONISTS AS PRIMARY THERAPY FOR PARKINSONS-DISEASE
OLANOW, CW
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1992, 19 (01) : 108 - 112
[30] A CASE FOR EARLY LEVODOPA TREATMENT OF PARKINSONS-DISEASE
CARACENI, T
CLINICAL NEUROPHARMACOLOGY, 1994, 17 : S38 - S42

← 1 2 3 4 5 →